κ Opioid Receptor Antagonism and Prodynorphin Gene Disruption Block Stress-Induced Behavioral Responses

Previous studies have demonstrated that stress may increase prodynorphin gene expression, and κ opioid agonists suppress drug reward. Therefore, we tested the hypothesis that stress-induced release of endogenous dynorphin may mediate behavioral responses to stress and oppose the rewarding effects of cocaine. C57Bl/6 mice subjected to repeated forced swim testing (FST) using a modified Porsolt procedure at 30°C showed a characteristic stress-induced immobility response and a stress-induced analgesia observed with a tail withdrawal latency assay. Pretreatment with the κ opioid receptor antagonist nor-binaltorphimine (nor-BNI; 10 mg/kg, i.p.) blocked the stress-induced analgesia and significantly reduced the stress-induced immobility. The nor-BNI sensitivity of the behavioral responses suggests an activation of the κ opioid receptor by a stress-induced release of dynorphin peptides. Supporting this hypothesis, transgenic mice possessing a disrupted prodynorphin gene showed no increase in immobility or stress-induced analgesia after exposure to repeated FST. Because both stress and the κ opioid system can modulate the response to drugs of abuse, we tested the effects of forced swim stress on cocaine-conditioned place preference (CPP). FST-exposed mice conditioned with cocaine (15 mg/kg, s.c.) showed significant potentiation of place preference for the drug-paired chamber over the responses of unstressed mice. Surprisingly, nor-BNI pretreatment blocked stress-induced potentiation of cocaine CPP. Consistent with this result, mice lacking the prodynorphin gene did not show a stress-induced potentiation of cocaine CPP, whereas wild-type littermates did. The findings suggest that chronic swim stress may activate the κ opioid system to produce analgesia, immobility, and potentiation of the acute rewarding properties of cocaine in C57Bl/6 mice.

[1]  B. Rounsaville,et al.  A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. , 1986, Archives of general psychiatry.

[2]  A. Dierich,et al.  Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses , 2000, Nature Genetics.

[3]  H. Emrich,et al.  Psychotomimesis mediated by kappa opiate receptors , 1986, Science.

[4]  Emilio Casanova,et al.  When reverse genetics meets physiology: the use of site‐specific recombinases in mice , 2002, FEBS letters.

[5]  P. Piazza,et al.  Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration , 1990, Brain Research.

[6]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[7]  R. Spanagel,et al.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Thase,et al.  Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. , 1998, The American journal of psychiatry.

[9]  A. Hidalgo,et al.  Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. , 1993, Brain research.

[10]  L. Yaswen,et al.  Generation of dynorphin knockout mice. , 2001, Brain research. Molecular brain research.

[11]  L. Miner.  Cocaine Reward and Locomotor Activity in C57BL/6J and 129/SvJ Inbred Mice and Their F1 Cross , 1997, Pharmacology Biochemistry and Behavior.

[12]  S. Cooper,et al.  The Neuropharmacological basis of reward , 1989 .

[13]  N. Hiroi,et al.  Regulation of cocaine reward by CREB. , 1998, Science.

[14]  A. Phillips,et al.  Conditioned place preference as a measure of drug reward. , 1989 .

[15]  T. Shippenberg,et al.  U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking , 1999, Psychopharmacology.

[16]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[17]  H. Akil,et al.  Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior , 2001, Psychopharmacology.

[18]  A. Hidalgo,et al.  Involvement of spinal κ opioid receptors in a type of footshock induced analgesia in mice , 1993, Brain Research.

[19]  G F Koob,et al.  Drug dependence: stress and dysregulation of brain reward pathways. , 1998, Drug and alcohol dependence.

[20]  J. Rosina,et al.  Influence of dynorphin A (1-13) and dynorphin A (1-10) amide on stress-induced analgesia. , 1996, Physiological research.

[21]  A. C. Thompson,et al.  Modulation of pre‐ and postsynaptic dopamine D2 receptor function by the selective kappa‐opioid receptor agonist U69593 , 2001, Synapse.

[22]  T. Kosten,et al.  Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience , 2000, Brain Research.

[23]  E. Nestler,et al.  Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens , 2001, The Journal of Neuroscience.

[24]  S. Maier,et al.  Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats. , 1980 .

[25]  I. Lucki,et al.  Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice , 2001, Psychopharmacology.

[26]  D. L. Rhoads.  A longitudinal study of life stress and social support among drug abusers. , 1983, The International journal of the addictions.

[27]  Chuan Yi Tang,et al.  A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..

[28]  T. Kameyama,et al.  Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. , 1992, Life sciences.

[29]  S. Sakurada,et al.  Changes in beta-endorphin and stress-induced analgesia in mice after exposure to forced walking stress. , 1999, Methods and findings in experimental and clinical pharmacology.

[30]  S. Maier,et al.  Uncontrollable Stress Potentiates Morphine’s Rewarding Properties , 1998, Pharmacology Biochemistry and Behavior.

[31]  J. Mogil,et al.  Opioid and Nonopioid Swim Stress-Induced Analgesia: A Parametric Analysis in Mice , 1996, Physiology & Behavior.

[32]  R. Quirion,et al.  Dynorphinergic pathways of Leu-Enkephalin production in the rat brain , 1985, Neuropeptides.

[33]  P. Romieu,et al.  Involvement of the Sigma1 Receptor in Cocaine-induced Conditioned Place Preference: Possible Dependence on Dopamine Uptake Blockade , 2002, Neuropsychopharmacology.

[34]  R. Przewłocki,et al.  The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord , 1987, Brain Research.

[35]  I. Lucki,et al.  Murine models of depression , 1999, Psychopharmacology.

[36]  N. Mello,et al.  Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. , 1998, The Journal of pharmacology and experimental therapeutics.

[37]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[38]  A. Takemori,et al.  Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. , 1979, The Journal of pharmacology and experimental therapeutics.

[39]  S. D. Glick,et al.  Kappa opioid inhibition of morphine and cocaine self-administration in rats , 1995, Brain Research.

[40]  R. G. Allen,et al.  Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. McEwen,et al.  Effects of adrenal steroid manipulations and repeated restraint stress on dynorphin mRNA levels and excitatory amino acid receptor binding in hippocampus , 1995, Brain Research.

[42]  Hee-Sup Shin,et al.  Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background , 1997, Neuron.

[43]  M. Kreek,et al.  Conditioned place preference after single doses or “binge” cocaine in C57BL/6J and 129/J mice , 2002, Pharmacology Biochemistry and Behavior.

[44]  T. Kameyama,et al.  Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. , 1990, The Journal of pharmacology and experimental therapeutics.

[45]  S. Maier,et al.  Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels , 1992, Brain Research.

[46]  E. Jutkiewicz,et al.  Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats , 2002, Neuropsychopharmacology.

[47]  H. Yamamura,et al.  Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. , 1992, The Journal of pharmacology and experimental therapeutics.

[48]  P. Portoghese,et al.  Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. , 1988, The Journal of pharmacology and experimental therapeutics.

[49]  M. Bardo,et al.  Conditioned place preference using opiate and stimulant drugs: A meta-analysis , 1995, Neuroscience & Biobehavioral Reviews.

[50]  J. Mendelson,et al.  Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies , 1997, Pharmacology Biochemistry and Behavior.

[51]  T. Kosten,et al.  Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats , 2001, Psychopharmacology.

[52]  M. Takahashi,et al.  Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. , 1990, Japanese journal of pharmacology.

[53]  Y. Shaham,et al.  Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats , 1994, Psychopharmacology.